AAAAAA

   
Results: 1-9 |
Results: 9
LACK OF DRUG-INTERACTIONS WITH IRBESARTAN - A SUMMARY OF 5 PHARMACOKINETIC STUDIES
Authors: MARINO MR LANGENBACHER KM MANGOLD B GIELSDORF W FORD N
Citation: Mr. Marino et al., LACK OF DRUG-INTERACTIONS WITH IRBESARTAN - A SUMMARY OF 5 PHARMACOKINETIC STUDIES, Journal of hypertension, 16, 1998, pp. 31096-31096
PHARMACOKINETICS AND PHARMACODYNAMICS OF IRBESARTAN IN PATIENTS WITH HEPATIC CIRRHOSIS
Authors: MARINO MR LANGENBACHER KM RAYMOND RH FORD NF LASSETER KC
Citation: Mr. Marino et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF IRBESARTAN IN PATIENTS WITH HEPATIC CIRRHOSIS, Journal of clinical pharmacology, 38(4), 1998, pp. 347-356
PHARMACOKINETICS AND ANTICOAGULANT EFFECT OF BMS-189664 FOLLOWING SINGLE ASCENDING ORAL AND IV DOSES IN HEALTHY MALE-SUBJECTS
Authors: HADJILAMBRIS OW MARINO MR LANGENBACHER KM FORD NF ZIELONKA J CLEMENTI R
Citation: Ow. Hadjilambris et al., PHARMACOKINETICS AND ANTICOAGULANT EFFECT OF BMS-189664 FOLLOWING SINGLE ASCENDING ORAL AND IV DOSES IN HEALTHY MALE-SUBJECTS, Clinical pharmacology and therapeutics, 63(2), 1998, p.
EFFECT OF HYDROCHLOROTHIAZIDE ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ANGIOTENSIN-II BLOCKER IRBESARTAN
Authors: MARINO MR LANGENBACHER KM FORD NE BEIERLE F RAYMOND RH SHAMBLEN EC LASSETER KC
Citation: Mr. Marino et al., EFFECT OF HYDROCHLOROTHIAZIDE ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ANGIOTENSIN-II BLOCKER IRBESARTAN, Clinical drug investigation, 14(5), 1997, pp. 383-391
THE EFFECT OF NEFAZODONE ON THE SINGLE-DOSE PHARMACOKINETICS OF PHENYTOIN IN HEALTHY MALE-SUBJECTS
Authors: MARINO MR LANGENBACHER KM HAMMETT JL NICHOLA P UDERMAN HD
Citation: Mr. Marino et al., THE EFFECT OF NEFAZODONE ON THE SINGLE-DOSE PHARMACOKINETICS OF PHENYTOIN IN HEALTHY MALE-SUBJECTS, Journal of clinical psychopharmacology, 17(1), 1997, pp. 27-33
EFFECT OF HYDROCHLOROTHIAZIDE ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF IRBESARTAN
Authors: MARINO MR LANGENBACHER KM FORD NF BEIERLE F SHAMBLEN EC LASSETER KC
Citation: Mr. Marino et al., EFFECT OF HYDROCHLOROTHIAZIDE ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF IRBESARTAN, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 52-52
SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF IRBESARTAN AFTER SINGLE AND MULTIPLE DOSES IN HEALTHY MALE-SUBJECTS
Authors: MARINO MR LANGENBACHER KM FORD NF UDERMAN HD
Citation: Mr. Marino et al., SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF IRBESARTAN AFTER SINGLE AND MULTIPLE DOSES IN HEALTHY MALE-SUBJECTS, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 53-53
INTERACTION OF NEFAZODONE (N) AND FLUOXETINE (F)
Authors: MARINO MR LANGENBACHER KM UDERMAN HD
Citation: Mr. Marino et al., INTERACTION OF NEFAZODONE (N) AND FLUOXETINE (F), Clinical pharmacology and therapeutics, 59(2), 1996, pp. 84-84
SYSTEMIC HEMODYNAMICS, RENAL-FUNCTION AND HORMONAL LEVELS DURING INHIBITION OF NEUTRAL ENDOPEPTIDASE 3.4.24.11 AND ANGIOTENSIN-CONVERTING ENZYME IN CONSCIOUS DOGS WITH PACING-INDUCED HEART-FAILURE
Authors: SEYMOUR AA ASAAD MM LANOCE VM LANGENBACHER KM FENNELL SA ROGERS WL
Citation: Aa. Seymour et al., SYSTEMIC HEMODYNAMICS, RENAL-FUNCTION AND HORMONAL LEVELS DURING INHIBITION OF NEUTRAL ENDOPEPTIDASE 3.4.24.11 AND ANGIOTENSIN-CONVERTING ENZYME IN CONSCIOUS DOGS WITH PACING-INDUCED HEART-FAILURE, The Journal of pharmacology and experimental therapeutics, 266(2), 1993, pp. 872-883
Risultati: 1-9 |